- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
According to our latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2022 and is forecast to a readjusted size of USD 3635.2 million by 2029 with a CAGR of 4.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report is a detailed and comprehensive analysis for global Tuberculosis (TB) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tuberculosis (TB) Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis (TB) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Roche, Thermo Fisher Scientific, BD and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Market segment by Application
Diagnostic Laboratories
Hospitals
Market segment by players, this report covers
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin and global market share of Tuberculosis (TB) Diagnostics from 2018 to 2023.
Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Tuberculosis (TB) Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis (TB) Diagnostics.
Chapter 13, to describe Tuberculosis (TB) Diagnostics research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Tuberculosis (TB) Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Tuberculosis (TB) Diagnostics by Type
1.3.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2022
1.3.3 Culture-Based Diagnostics
1.3.4 Sputum Smear Microscopy
1.3.5 Rapid Molecular Diagnostics
1.3.6 Others
1.4 Global Tuberculosis (TB) Diagnostics Market by Application
1.4.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnostic Laboratories
1.4.3 Hospitals
1.5 Global Tuberculosis (TB) Diagnostics Market Size & Forecast
1.6 Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Region
1.6.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Tuberculosis (TB) Diagnostics Market Size by Region, (2018-2029)
1.6.3 North America Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
1.6.4 Europe Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
1.6.6 South America Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions
2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions
2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions
2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BD Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions
2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Hologic
2.6.1 Hologic Details
2.6.2 Hologic Major Business
2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions
2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hologic Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 BioMerieux
2.8.1 BioMerieux Details
2.8.2 BioMerieux Major Business
2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BioMerieux Recent Developments and Future Plans
2.9 Hain Lifescience
2.9.1 Hain Lifescience Details
2.9.2 Hain Lifescience Major Business
2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hain Lifescience Recent Developments and Future Plans
2.10 Oxford Immunotec
2.10.1 Oxford Immunotec Details
2.10.2 Oxford Immunotec Major Business
2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Oxford Immunotec Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Tuberculosis (TB) Diagnostics by Company Revenue
3.2.2 Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2022
3.2.3 Top 6 Tuberculosis (TB) Diagnostics Players Market Share in 2022
3.3 Tuberculosis (TB) Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Tuberculosis (TB) Diagnostics Market: Region Footprint
3.3.2 Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
3.3.3 Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Tuberculosis (TB) Diagnostics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2023)
5.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
6.2 North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country
6.3.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
6.3.2 United States Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
7.2 Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country
7.3.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
7.3.2 Germany Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
7.3.3 France Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
7.3.5 Russia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
7.3.6 Italy Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region
8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2018-2029)
8.3.2 China Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
8.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
8.3.4 South Korea Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
8.3.5 India Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
8.3.7 Australia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
9.2 South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
9.3 South America Tuberculosis (TB) Diagnostics Market Size by Country
9.3.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
9.3.2 Brazil Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
9.3.3 Argentina Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
10.3.2 Turkey Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
10.3.4 UAE Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Tuberculosis (TB) Diagnostics Market Drivers
11.2 Tuberculosis (TB) Diagnostics Market Restraints
11.3 Tuberculosis (TB) Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Tuberculosis (TB) Diagnostics Industry Chain
12.2 Tuberculosis (TB) Diagnostics Upstream Analysis
12.3 Tuberculosis (TB) Diagnostics Midstream Analysis
12.4 Tuberculosis (TB) Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Danaher Company Information, Head Office, and Major Competitors
Table 6. Danaher Major Business
Table 7. Danaher Tuberculosis (TB) Diagnostics Product and Solutions
Table 8. Danaher Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Danaher Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Tuberculosis (TB) Diagnostics Product and Solutions
Table 13. Roche Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Roche Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
Table 18. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. BD Company Information, Head Office, and Major Competitors
Table 21. BD Major Business
Table 22. BD Tuberculosis (TB) Diagnostics Product and Solutions
Table 23. BD Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BD Recent Developments and Future Plans
Table 25. Abbott Company Information, Head Office, and Major Competitors
Table 26. Abbott Major Business
Table 27. Abbott Tuberculosis (TB) Diagnostics Product and Solutions
Table 28. Abbott Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Abbott Recent Developments and Future Plans
Table 30. Hologic Company Information, Head Office, and Major Competitors
Table 31. Hologic Major Business
Table 32. Hologic Tuberculosis (TB) Diagnostics Product and Solutions
Table 33. Hologic Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Hologic Recent Developments and Future Plans
Table 35. Qiagen Company Information, Head Office, and Major Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
Table 38. Qiagen Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Qiagen Recent Developments and Future Plans
Table 40. BioMerieux Company Information, Head Office, and Major Competitors
Table 41. BioMerieux Major Business
Table 42. BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
Table 43. BioMerieux Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. BioMerieux Recent Developments and Future Plans
Table 45. Hain Lifescience Company Information, Head Office, and Major Competitors
Table 46. Hain Lifescience Major Business
Table 47. Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
Table 48. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Hain Lifescience Recent Developments and Future Plans
Table 50. Oxford Immunotec Company Information, Head Office, and Major Competitors
Table 51. Oxford Immunotec Major Business
Table 52. Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
Table 53. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Oxford Immunotec Recent Developments and Future Plans
Table 55. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Players (2018-2023)
Table 56. Global Tuberculosis (TB) Diagnostics Revenue Share by Players (2018-2023)
Table 57. Breakdown of Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Tuberculosis (TB) Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Tuberculosis (TB) Diagnostics Players
Table 60. Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
Table 61. Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
Table 62. Tuberculosis (TB) Diagnostics New Market Entrants and Barriers to Market Entry
Table 63. Tuberculosis (TB) Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Tuberculosis (TB) Diagnostics Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2018-2023)
Table 66. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Type (2024-2029)
Table 67. Global Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023)
Table 68. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Application (2024-2029)
Table 69. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Tuberculosis (TB) Diagnostics Raw Material
Table 100. Key Suppliers of Tuberculosis (TB) Diagnostics Raw Materials
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2022
Figure 4. Culture-Based Diagnostics
Figure 5. Sputum Smear Microscopy
Figure 6. Rapid Molecular Diagnostics
Figure 7. Others
Figure 8. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application in 2022
Figure 10. Diagnostic Laboratories Picture
Figure 11. Hospitals Picture
Figure 12. Global Tuberculosis (TB) Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Tuberculosis (TB) Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Tuberculosis (TB) Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region in 2022
Figure 17. North America Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Tuberculosis (TB) Diagnostics Revenue Share by Players in 2022
Figure 23. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Tuberculosis (TB) Diagnostics Market Share in 2022
Figure 25. Global Top 6 Players Tuberculosis (TB) Diagnostics Market Share in 2022
Figure 26. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2018-2023)
Figure 27. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Type (2024-2029)
Figure 28. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Application (2018-2023)
Figure 29. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Application (2024-2029)
Figure 30. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 40. France Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 47. China Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 50. India Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 64. Tuberculosis (TB) Diagnostics Market Drivers
Figure 65. Tuberculosis (TB) Diagnostics Market Restraints
Figure 66. Tuberculosis (TB) Diagnostics Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Tuberculosis (TB) Diagnostics in 2022
Figure 69. Manufacturing Process Analysis of Tuberculosis (TB) Diagnostics
Figure 70. Tuberculosis (TB) Diagnostics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
